Dr. Maurie Markman suggests that the findings of this study be shared with women with the BRCA+ mutation.

Dr. Mark Kris stresses that EGFR-targeted therapies provide no benefit in lung cancer patients who have no activating mutations, as evidenced in a recent study.

Donald Berwick talks with Eric Topol about his decades-long career with the Institute for Healthcare Improvement, his tenure as Director of CMS, and why he's running for governor of Massachusetts.

Providers must be more proactive if we are to raise national colorectal cancer screening rates.

Dr. Maurie Markman reviews a recent study looking at genetic mutations and possible therapeutic targets in squamous cell carcinoma of the lung.

Drs. Kathy Miller and Ian Krop talk about why a single-arm study in low-risk cancer is a huge advance for a population of understudied breast cancer patients.

A man suffered a tragic, sudden accident and woke up paralyzed and with a breathing tube. Doctors asked him whether he wanted to continue living. Should they have waited?

Dr. Maurie Markman considers how 'normal' genetic variants can influence cancer treatment outcome.

Nearly 2 decades after the furor over Lucian Leape's 'Error in Medicine,' the number of hospital deaths related to medical errors continues to grow.

A 29-year-old Stanford dropout has developed a new biotechnology that threatens to give laboratory medicine its biggest shakeup in decades.